The Lumenis Stellar M22 is a multi-modality laser platform integrating Intense Pulsed Light (IPL), ResurFX (1565 nm non-ablative fractional laser), and Nd:YAG (long-pulsed and Q-switched 1064 nm) technologies. This system addresses over 30 indications, including skin rejuvenation, pigmentation, vascular lesions, acne scars, hair removal, tattoo removal, and dry eye disease due to meibomian gland dysfunction. At Cosmetic Injectables Center Medspa, all treatments are performed by certified experts under the direct supervision of Dr. Sherly Soleiman, MD, a board-certified physician and national faculty trainer.
How the Lumenis Stellar M22 Platform Works
IPL (Intense Pulsed Light)
IPL uses a broad spectrum of light (515–1200 nm) with customizable filters to target pigmentation, vascular lesions, and photoaging. The Stellar M22’s Optimal Pulse Technology allows for precise energy delivery, minimizing risk and downtime.
Clinical Evidence: FDA-cleared for benign pigmented and vascular lesions, hair removal, and dry eye management (OptiLIGHT). Studies confirm >70% clearance rates for pigmentation and vascular lesions, with histological evidence of collagen remodeling (FDA K250809, PMC3806078).
ResurFX (1565 nm Non-Ablative Fractional Laser)
ResurFX delivers fractional laser energy to stimulate neocollagenesis and improve skin texture, scars, and enlarged pores, without ablating the epidermis.
Clinical Evidence: Peer-reviewed studies show a 29% reduction in pore count after five sessions, with high patient satisfaction and minimal downtime (PMC9525434). Histology confirms increased dermal collagen density.
Nd:YAG (Long-Pulsed and Q-Switched 1064 nm)
The Nd:YAG module targets deeper vascular lesions, pigmentation, and tattoos. Q-switched mode is effective for melanin reduction and tattoo removal, while long-pulsed mode treats vascular structures.
Clinical Evidence: A 2024 pilot study demonstrated improved skin tone and texture, reduced melanin index, and increased collagen density after seven treatments, with minimal side effects (PubMed 38592205).
Indications and Clinical Applications
| Indication | IPL | ResurFX | Nd:YAG (LP/QS) |
|---|---|---|---|
| Photoaging | ✓ | ✓ | ✓ |
| Pigmentation (Sun Spots, Melasma) | ✓ | ✓ | ✓ (QS) |
| Vascular Lesions (Rosacea, Veins) | ✓ | ✓ (LP) | |
| Acne Scars | ✓ | ||
| Enlarged Pores | ✓ | ||
| Hair Removal | ✓ | ||
| Tattoo Removal | ✓ (QS) | ||
| Dry Eye (MGD) | ✓ (OptiLIGHT) | ||
| Skin Resurfacing | ✓ |
Legend: ✓ = Supported by clinical evidence and FDA clearance
Regulatory and Scientific Evidence
FDA Clearances and Regulatory Status
- Stellar M22 IPL: Cleared for benign pigmented/vascular lesions, hair removal, and dry eye (OptiLIGHT) (FDA K250809, DEN200028).
- ResurFX: Cleared for non-ablative skin resurfacing and scar treatment.
- Nd:YAG: Cleared for vascular lesions and tattoo removal.
Key Clinical Studies
- IPL for Dry Eye (MGD): Randomized controlled trials show improved tear break-up time, gland function, and symptom scores with low adverse event rates (PMC9223330, Federal Register).
- ResurFX for Texture and Pores: Comparative studies report a 29% reduction in pore count and high satisfaction after five sessions (PMC9525434).
- Nd:YAG for Skin Rejuvenation: Pilot studies confirm reduced pigmentation and increased collagen, with over 80% of participants reporting visible improvement (PubMed 38592205).
Histological Insights
- IPL and Nd:YAG treatments induce neocollagenesis and vessel coagulation, confirmed by biopsy in foundational and recent studies (PMC3806078, PubMed 38592205).
- ResurFX promotes dermal remodeling without ablating the epidermis, supporting its safety and efficacy for texture improvement.
Comparison Table: IPL vs. ResurFX vs. Nd:YAG
| Feature/Parameter | IPL (Stellar M22) | ResurFX (1565 nm) | Nd:YAG (1064 nm, LP/QS) |
|---|---|---|---|
| Technology Type | Broad-spectrum light | Non-ablative fractional laser | Long-pulsed/Q-switched laser |
| Wavelength Range | 515–1200 nm (multiple filters) | 1565 nm | 1064 nm |
| Main Indications | Pigmentation, vascular, hair, dry eye | Texture, scars, pores, resurfacing | Vascular, pigmentation, tattoos |
| FDA Clearance | Yes (multiple indications) | Yes (resurfacing, scars) | Yes (vascular, tattoo removal) |
| Downtime | Minimal | Minimal-moderate (redness/edema) | Minimal (transient erythema) |
| Fitzpatrick Skin Types | I–V (with proper settings) | I–V (caution in higher types) | I–VI (especially Q-switched) |
| Pain Level | Mild (numbing/cooling used) | Mild-moderate (numbing used) | Mild (numbing/cooling used) |
| Sessions Required | 3–6 (varies by indication) | 3–5+ (texture/scars) | 3–7 (pigment/vascular/tattoo) |
| Histological Effect | Collagen remodeling, vessel coagulation | Neocollagenesis, dermal remodeling | Collagen increase, pigment fragmentation |
Safety, Patient Selection, and Treatment Experience
The Stellar M22 is validated for Fitzpatrick skin types I–V (and VI in some Nd:YAG protocols), with built-in safety features such as real-time cooling and customizable pulse durations. Most side effects are mild and transient, including erythema, edema, and temporary discomfort. All procedures at Cosmetic Injectables Center Medspa are performed by certified providers under the direct supervision of Dr. Soleiman, who is recognized nationally for her expertise in laser and injectable treatments.
Pain and bruising are minimized using advanced techniques, including topical numbing, cold compresses, and vibration devices. Patients receive a comprehensive Good Faith Exam and full informed consent prior to treatment.
Why Choose Cosmetic Injectables Center Medspa for Stellar M22 Treatments?
- Physician-Led Care: Dr. Sherly Soleiman, MD, a board-certified physician and national faculty trainer, oversees all protocols and provides direct supervision (AMA Profile).
- Certified Expert Providers: All treatments are performed by certified injectors and licensed clinicians with advanced training in laser safety and efficacy.
- Top 1% National Ranking: Recognized as an Allergan Top 250 practice, reflecting elite experience and outcomes.
- Safety and Natural Results: The practice follows a conservative, “less is more” philosophy to achieve subtle, natural-looking results.
- Comprehensive Services: The Stellar M22 platform is part of a full suite of nonsurgical medical aesthetic procedures, including laser skin resurfacing, IPL photorejuvenation, and tattoo removal.
Frequently Asked Questions
What is the Lumenis Stellar M22 used for?
The Stellar M22 treats pigmentation, vascular lesions, skin texture, acne scars, hair removal, tattoo removal, and dry eye due to meibomian gland dysfunction.
How many sessions are needed for results?
Most patients require 3–6 sessions, depending on the indication and individual response. Maintenance treatments may be recommended.
Is there downtime after Stellar M22 treatments?
Downtime is minimal. Most patients experience mild redness or swelling that resolves within a few days.
Is the Stellar M22 safe for all skin types?
The device is validated for Fitzpatrick I–V and, in some protocols, VI. Settings are adjusted for safety in darker skin tones.
What makes IPL different from ResurFX and Nd:YAG?
IPL uses broad-spectrum light for pigmentation and vascular issues. ResurFX is a fractional laser for texture and scars. Nd:YAG targets deeper pigment and vascular lesions.
Can Stellar M22 treat dry eye?
Yes, the IPL module (OptiLIGHT) is FDA-cleared for managing dry eye due to meibomian gland dysfunction in adults.
Are treatments painful?
Most patients report mild discomfort, managed with topical numbing and cooling. Pain is generally brief and well-tolerated.
Who performs the procedures at Cosmetic Injectables Center Medspa?
Certified expert injectors and licensed clinicians, all under the direct supervision of Dr. Sherly Soleiman, MD.
Are results permanent?
Some results, such as hair reduction and tattoo removal, can be long-lasting. Maintenance may be needed for skin rejuvenation.
Is a consultation required?
Yes, all patients receive a comprehensive consultation and Good Faith Exam to determine candidacy and customize treatment.